Touchstone International Medical Science Co Ltd (688013) - Total Assets
Based on the latest financial reports, Touchstone International Medical Science Co Ltd (688013) holds total assets worth CN¥676.02 Million CNY (≈ $98.92 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Touchstone International Medical Science for net asset value and shareholders' equity analysis.
Touchstone International Medical Science Co Ltd - Total Assets Trend (2017–2024)
This chart illustrates how Touchstone International Medical Science Co Ltd's total assets have evolved over time, based on quarterly financial data.
Touchstone International Medical Science Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Touchstone International Medical Science Co Ltd's total assets of CN¥676.02 Million consist of 69.9% current assets and 30.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.1% |
| Accounts Receivable | CN¥12.99 Million | 2.0% |
| Inventory | CN¥30.77 Million | 4.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥39.85 Million | 6.3% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Touchstone International Medical Science Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Touchstone International Medical Science worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Touchstone International Medical Science Co Ltd's current assets represent 69.9% of total assets in 2024, an increase from 42.5% in 2017.
- Cash Position: Cash and equivalents constituted 10.1% of total assets in 2024, down from 23.2% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 3.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 6.3% of total assets.
Touchstone International Medical Science Co Ltd Competitors by Total Assets
Key competitors of Touchstone International Medical Science Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Teleflex Incorporated
NYSE:TFX
|
USA | $6.95 Billion |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
Crossject
PA:ALCJ
|
France | €31.38 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Touchstone International Medical Science Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.35 | 5.19 | 23.03 |
| Quick Ratio | 5.74 | 4.76 | 21.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥357.75 Million | CN¥403.61 Million | CN¥392.47 Million |
Touchstone International Medical Science Co Ltd - Advanced Valuation Insights
This section examines the relationship between Touchstone International Medical Science Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.84 |
| Latest Market Cap to Assets Ratio | 0.66 |
| Asset Growth Rate (YoY) | 1.7% |
| Total Assets | CN¥637.24 Million |
| Market Capitalization | $419.80 Million USD |
Valuation Analysis
Below Book Valuation: The market values Touchstone International Medical Science Co Ltd's assets below their book value (0.66x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Touchstone International Medical Science Co Ltd's assets grew by 1.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Touchstone International Medical Science Co Ltd (2017–2024)
The table below shows the annual total assets of Touchstone International Medical Science Co Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥637.24 Million ≈ $93.25 Million |
+1.70% |
| 2023-12-31 | CN¥626.61 Million ≈ $91.69 Million |
+15.30% |
| 2022-12-31 | CN¥543.46 Million ≈ $79.52 Million |
-0.25% |
| 2021-12-31 | CN¥544.83 Million ≈ $79.73 Million |
+12.28% |
| 2020-12-31 | CN¥485.24 Million ≈ $71.01 Million |
+288.49% |
| 2019-12-31 | CN¥124.91 Million ≈ $18.28 Million |
+6.80% |
| 2018-12-31 | CN¥116.95 Million ≈ $17.11 Million |
+18.66% |
| 2017-12-31 | CN¥98.57 Million ≈ $14.42 Million |
-- |
About Touchstone International Medical Science Co Ltd
Touchstone International Medical Science Co., Ltd. researches and develops, manufactures, and sells medical devices in China, the United States, Europe, Japan, Russia, Brazil, South Korea, Canada, Australia, and internationally. It provides laparoscopic, tube-type, intraluminal, endoscopic linear cutters and reloads, linear cutters and reloads, auto purse string clamps, and linear staplers and re… Read more